BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1710959)

  • 1. Method for kinetic analysis of drug-induced cell cycle perturbations.
    Ubezio P; Filippeschi S; Spinelli L
    Cytometry; 1991; 12(2):119-26. PubMed ID: 1710959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.
    Tsurusawa M; Niwa M; Katano N; Fujimoto T
    Cancer Res; 1988 Aug; 48(15):4288-93. PubMed ID: 3390825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
    BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell kinetics in mouse epidermis studied by bivariate DNA/bromodeoxyuridine and DNA/keratin flow cytometry.
    Kirkhus B; Clausen OP
    Cytometry; 1990; 11(2):253-60. PubMed ID: 1690627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
    Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
    Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle analysis using numerical simulation of bivariate DNA/bromodeoxyuridine distributions.
    Yanagisawa M; Dolbeare F; Todoroki T; Gray JW
    Cytometry; 1985 Nov; 6(6):550-62. PubMed ID: 4064838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric BrdUrd-pulse-chase study of X-ray-induced alterations in cell cycle progression.
    Higashikubo R; Ragouzis M; Roti Roti JL
    Cell Prolif; 1996 Jan; 29(1):43-57. PubMed ID: 8603109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle perturbation of cultured C6 glioma cells following short-term contact with a low dose of ACNU.
    Genka S; Shitara N; Tsujita Y; Kosugi Y; Wu Y; Takakura K
    Cytometry; 1987 Jul; 8(4):386-91. PubMed ID: 3476287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-induced cytostasis: kinetic analysis of bromodeoxyuridine-pulsed cells.
    Stevenson AP; Crissman HA; Stewart CC
    Cytometry; 1985 Nov; 6(6):578-83. PubMed ID: 4064839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.
    Fujikane T; Shimizu T; Tsuji T; Ishida S; Ohsaki Y; Onodera S
    Cytometry; 1989 Nov; 10(6):788-95. PubMed ID: 2582970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling.
    Baisch H; Otto U; Hatje U; Fack H
    Cytometry; 1995 Sep; 21(1):52-61. PubMed ID: 8529471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of an S phase population of cells without DNA synthesis generated by cisplatin and pentoxifylline.
    Perras JP; Ramos R; Sevin BU
    Cytometry; 1993; 14(4):441-8. PubMed ID: 8513698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoblasts already in the DNA synthesis phase of the cell cycle can be reversibly arrested at the R/G transition.
    Lavoie J; Drouin R
    Chromosoma; 2001 Dec; 110(7):501-10. PubMed ID: 11862457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cell cycle duration by c-myc levels.
    Karn J; Watson JV; Lowe AD; Green SM; Vedeckis W
    Oncogene; 1989 Jun; 4(6):773-87. PubMed ID: 2660073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting cell cycle effects of drugs: the case of melphalan.
    Lupi M; Cappella P; Matera G; Natoli C; Ubezio P
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):443-57. PubMed ID: 16195878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell kinetic changes in cultured tumor cells after treatment with radiation and chemotherapy.
    Murata T; Akagi K; Uda M; Kimura H; Nasu R; Tanaka Y
    Int J Oncol; 1998 Jan; 12(1):171-4. PubMed ID: 9454901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of cytosine arabinoside resistant cells at low frequency using the bromodeoxyuridine/DNA assay.
    Waldman FM; Dolbeare F; Gray JW
    Cytometry; 1985 Nov; 6(6):657-62. PubMed ID: 4064845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.